HER-2 as a potential target for rectal cancer treatment: Positivity rate in patients of the CAO/ARO/AIO-94 and-04 trial.

被引：0
|
作者：
Conradi, Lena-Christin
Storch, Marcus
Nagelmeier, Iris
Styczen, Hanna
Wolff, Hendrik A.
Gaedcke, Jochen
Sprenger, Thilo
Homayounfar, Kia
Ghadimi, Michael
Rueschoff, Josef
Beissbarth, Tim
Roedel, Claus
Liersch, Torsten
机构：
[1] Univ Med Ctr, Gen Visceral & Pediat Surg, Gottingen, Germany
[2] Inst Pathol Nordhessen, Kassel, Germany
[3] Univ Med Ctr, Gen & Visceral Surg, Gottingen, Germany
[4] Univ Med Ctr, Dept Radiooncol, Gottingen, Germany
[5] Univ Gottingen, Univ Med Ctr, Dept Gen Visceral & Pediat Surg, D-37073 Gottingen, Germany
[6] Targos Mol Pathol GmbH, Kassel, Germany
[7] Univ Gottingen, Univ Med Ctr, Dept Med Stat, D-37073 Gottingen, Germany
[8] Goethe Univ Frankfurt, Dept Radiotherapy & Oncol, D-60054 Frankfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：1
相关论文
共 24 条
  • [21] Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup
    Sprenger, Thilo
    Rothe, Hilka
    Conradi, Lena-Christin
    Beissbarth, Tim
    Kauffels, Anne
    Kitz, Julia
    Homayounfar, Kia
    Wolff, Hendrik
    Stroebel, Philipp
    Ghadimi, Michael
    Wittekind, Christian
    Sauer, Rolf
    Roedel, Claus
    Liersch, Torsten
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : 377 - 385
  • [22] Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial
    Diefenhardt, Markus
    Ludmir, Ethan B.
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Minsky, Bruce D.
    Fleischmann, Max
    Fokas, Emmanouil
    Rodel, Claus
    RADIOTHERAPY AND ONCOLOGY, 2021, 164 : 223 - 231
  • [23] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial.
    Rodel, Claus
    Liersch, Torsten
    Fietkau, Rainer
    Hohenberger, Werner
    Graeven, Ullrich
    Hothorn, Torsten
    Arnold, Dirk
    Raab, Hans-Rudolf
    Wittekind, Christian
    Hess, Clemens F.
    Staib, Ludger
    Becker, Heinz
    Sauer, Rolf
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Importance of the Body Mass Index on the Therapy cycle, the operative Result and the long-term clinical Outcome in the multimodal Treatment of Patients with Rectal Cancer. A secondary Analysis of the randomized-Phase III CAO/ARO/AIO-04 Rectal Cancer Study
    Diefenhardt, M.
    Ludmir, E.
    Hofheinz, R-D
    Ghadimi, M.
    Minsky, B.
    Fleischmann, M.
    Fokas, E.
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S35 - S36
123